SG Americas Securities LLC grew its stake in Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 38.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,490 shares of the company’s stock after purchasing an additional 5,392 shares during the period. SG Americas Securities LLC’s holdings in Cardlytics were worth $72,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently modified their holdings of the stock. Tallon Kerry Patrick bought a new stake in Cardlytics during the 4th quarter worth approximately $37,000. Sanctuary Advisors LLC bought a new stake in Cardlytics during the 3rd quarter worth approximately $82,000. Barclays PLC grew its position in Cardlytics by 223.9% during the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock worth $186,000 after acquiring an additional 40,112 shares during the last quarter. Geode Capital Management LLC grew its position in Cardlytics by 7.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after acquiring an additional 73,484 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new position in Cardlytics in the 3rd quarter valued at $63,000. 68.10% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $6.92.
Cardlytics Stock Performance
Shares of Cardlytics stock opened at $3.48 on Friday. The company has a market capitalization of $176.85 million, a PE ratio of -0.57 and a beta of 1.54. Cardlytics, Inc. has a 12 month low of $2.76 and a 12 month high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The stock’s fifty day simple moving average is $3.50 and its 200 day simple moving average is $3.88.
Insider Buying and Selling
In other Cardlytics news, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $3.92, for a total value of $59,427.20. Following the sale, the chief executive officer now owns 215,494 shares of the company’s stock, valued at $844,736.48. This trade represents a 6.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Alexis Desieno sold 8,854 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the completion of the transaction, the chief financial officer now owns 121,976 shares of the company’s stock, valued at $447,651.92. The trade was a 6.77 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,819 shares of company stock valued at $148,305. 4.40% of the stock is owned by company insiders.
Cardlytics Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- What is the Hang Seng index?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Effectively Use the MarketBeat Ratings Screener
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLX – Free Report).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.